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850Objectives: We sought to investigate the feasibility and safety of totally thoracoscopic repair of a ventricular
septal defect.
Methods: Totally thoracoscopic repair of a perimembranous ventricular septal defect was performed in 36 pa-
tients (16 male patients; age, 5–19 years; average age, 10.2 4.5 years). Patients with a pulmonary arterial sys-
tolic pressure of 60 mm Hg or greater or with supracristal or muscular ventricular septal defects were excluded.
An additional 16 patients undergoing open-chest ventricular septal defect repair were selected as a control
group. Through 3 port incisions in the right chest, pericardiotomy, bicaval occlusion, atriotomy, and ventricular
septal defect repair were performed by a surgeon by means of thoracoscopy.
Results: The cardiopulmonary bypass and aortic crossclamp times were 66.2  21.3 and 36.4  8.2 minutes,
respectively. The length of stay in the intensive care unit was 20.0 4.1 hours. There were no mortalities and no
major complications. Transesophageal echocardiographic analysis 5.2 3.6 months after the operation showed
complete closure of the defect without residual shunt. The intensive care unit (17 2 vs 25 5 hours, P¼ .01)
or postoperative hospital (4.2  1.1 vs 6.7  2.1 days, P ¼ .03) stays in the thoracoscopic group were shorter
than in the control group. The percentage of patients who required postoperative opioid analgesics in the
thoracoscopic group was lower than in the control group (37.5% vs 87.5%, P ¼ .001).
Conclusions: Totally thoracoscopic repair of a perimembranous ventricular septal defect is feasible and safe for
older children. This technique is associated with a reduced intensive care and hospital stay in comparison with
conventional ventricular septal defect repair. (J Thorac Cardiovasc Surg 2011;142:850-4)Minimally invasive cardiac surgery has been used in re-
cent years for atrial septal defect (ASD) or ventricular
septal defect (VSD) closure.1-3 These procedures are
characterized by the performance of complex cardiac
surgical procedures through smaller incisions and are
often facilitated by computers and an endoscopic camera
to guide the manipulation of surgical instruments
through small thoracic incisions.4 In recent years, totally
endoscopic procedures have been reported to be a safe
and effective method, with a rapid recovery of quality of
life and lower pain levels compared with both median
sternotomy and minithoracotomy.5-8
Totally endoscopic procedures remain highly complex and
require the assistance of computer and robotic technologies.
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The Journal of Thoracic and Cardiovascular Surggenital defects, such asASDs.5-8 The effectiveness and safety
of totally endoscopic repair of a VSD have not been
extensively investigated. Moreover, almost all the currently
reported totally endoscopic repairs of ASDs were assisted
by the robotic Da Vinci Surgical System.5-8 The aim of
this study was to describe the feasibility, indications,
limitations, and problems of totally thoracoscopic repair of
a VSD through a 3-port entry approach without the aid of
a robotically assisted surgical system.MATERIALS AND METHODS
Patient Selection
This study was approved by the Institutional Review Board of Liao-
cheng People’s Hospital. Written informed consent was obtained from
all participants before the study. The total annual number of pediatric op-
erations in the department of cardiac surgery is approximately 250. With
smaller children (5 years old) we perform conventional open-chest
VSD closure. Open-chest VSD closure is also performed in patients with
supracristal (conal septal, infundibular, subpulmonic, subarterial, subarte-
rial doubly committed, and outlet) or muscular VSDs. For this study, we
screened 85 patients with VSDs between June 2009 and March 2010, of
whom 36 met the selection criteria and provided written consent for thor-
acoscopic closure. In the same time period, 16 patients who met the criteria
for thoracoscopic closure but opted to receive conventional open-chest
surgery were registered as a control group.
For thoracoscopic VSD closure, both of the following 2 selection crite-
ria must be met: (1) presence of a perimembranous VSD of any size and
(2) patient older than 5 years with a body weight of more than 20 kg. Ex-
clusion criteria are any one of the following: (1) supracristal or muscularery c October 2011
Abbreviations and Acronyms
ASD ¼ atrial septal defect
CPB ¼ cardiopulmonary bypass
VSD ¼ ventricular septal defect
Ma et al Congenital Heart DiseaseVSD; (2) pulmonary arterial systolic pressure (measured bymeans of echo-
cardiographic analysis) of 60 mmHg or greater; (3) history of lung disease,
right-sided chest operation, or adhesions of the right pleural membrane; (4)
concurrent cardiovascular disease or chronic illnesses; and (5) inability to
provide informed consent.FIGURE 1. Location of the 3 ports on the right chest wall.Anesthesia
After induction of general anesthesia, a left-sided double-lumen endo-
tracheal tube (50 kg) or single-lumen endotracheal tube (<50 kg) was
placed to allow for single-lung ventilation. The respiration rate was set be-
tween 18 and 30 breaths/min, and the arterial oxygen saturation rate was
maintained at greater than 97%. After the induction of general anesthesia,
a transesophageal echocardiographic probe was inserted to monitor the
VSD repair.C
H
DSurgical Techniques
The patient was positioned in a 15 to 20 left lateral decubitus position.
After systemic heparinization, the right femoral artery and vein were ac-
cessed through an oblique incision along the inguinal crease, as previously
reported by Bonaros and colleagues.7 A 24F/29F Carpentier double-lumen
catheter (Medtronic, Minneapolis, Minn) was inserted through the right
femoral vein into the inferior and superior venae cavae. The bypass circuit
was completed by positioning a 17F or 21F catheter (Medtronic) in the
abdominal aorta through the right femoral artery.
Three small incisions (ports) were made on the right side of the chest
(Figure 1). Port 1 (1–1.5 cm) was located in the fourth intercostal space
on the right side of the sternum (Figure 1). This port was for the insertion
of surgical instruments, such as tissue forceps or suture needles, with the
left hand (for a right-handed operator). Port 2 (1–1.5 cm) was for the entry
of instruments, such as scissors, handled by the right hand of the operator. It
is located in the sixth intercostal space on a midclavicular line (Figure 1).
Port 3 (1.5–2.0 cm) was located in the fifth intercostal space on the right
midaxillary line (Figure 1). This port was for the placement of an endo-
scopic camera or thoracoscopy. A self-made plastic retractor was inserted
into each of the 3 ports to keep the ports open and to facilitate the insertion
or withdrawal of the instruments or thoracoscopy (Figure 2). A conven-
tional Olympus OTV-S7 thoracoscope (Olympus Corp, Tokyo, Japan)
was used in this study. Other surgical instruments, such as forceps or
scissors, were conventional instruments for thoracoscopic surgery (Scanlan
International, St Paul, Minn).
Once the 3 ports were secured, pericardiotomy was performed, and 3 to
4 sutures were placed to suspend the pericardium. Caval snares were placed
in the superior and inferior venae cavae to install total cardiopulmonary by-
pass (CPB). After CPB initiation and cooling to 32C, the thoracoscopy
was placed through port 2 to visualize the root of the aorta. An aortic cross-
clamp was positioned on the ascending aorta (Figure 3). A needle was in-
serted through port 3 to the aortic root for the delivery of cold St Thomas
cardioplegic solution to achieve cardiac arrest (Figure 3). The thoracoscopy
was repositioned through port 3 to visualize the right atrium. A tissue for-
ceps and a scissors were entered through ports 1 and 2, respectively
(Figure 2). After snaring of the superior and inferior venae cavae, the right
atriumwas opened from a site parallel to the atrioventricular annulus, and 4
stay sutures were placed on the incision to expose the intra-atrial structure.
A 3-mm incision was made on the fossa ovalis for the insertion of the leftThe Journal of Thoracic and Caatrial drainage tube. The tricuspid valves were pulled apart to expose the
VSD. For a defect of less than 6 mm, direct sutures (4–0 Proline; Ethicon,
Somerville, NJ) were used for closure (Figure 4). A bovine patch (Bairen
Med Pharma Co, Beijing, China) was used to repair defects of 6 mm or
larger with running Prolene sutures. The DeVega technique was used to
repair tricuspid valve regurgitation.
After VSD closure, the incisions in the fossa ovalis and the right atrium
were closed. Deairing was performed through the perfusion needle at the
root of the aorta through negative pressure. The aortic crossclamp was re-
leased, and the patient was rewarmed. The patient was weaned from CPB.
Integrity of the VSD closure was confirmed by means of transesophageal
echocardiographic analysis, and protamine sulfate (1:1) was administered.
After adequate hemostasis was achieved, all instruments were removed
from the chest, and a 24F chest tube was inserted in the right pleural space
through port 2 for drainage. Finally, the cannulas in the right femoral vein
and artery were removed, and incisions on the blood vessels were closed
with sutures.
Sixteen consecutive patients undergoing open-chest repair for perimem-
branous VSD were selected between June 2009 and March 2010 to
compare operational data and the requirement for postoperative analgesics
between conventional and thoracoscopic VSD closure. These patients were
matched in terms of demographics andVSD typewith the last 16 patients in
the thoracoscopic group.
Perioperative Management
Before the operation, education and counseling were provided to all
participants on surgical techniques, possible clinical outcomes, potential
complications, and postoperative self-care measures. Lung function tests
were routinely performed in all patients before the operation. The lungs
were inflated every 20 minutes during the operation. After the operation,
patients were monitored in the intensive care unit overnight and received
low-frequency, high-volume mechanical ventilation with a peak end-
expiratory pressure of 3 to 5 cm H2O. Bedside chest radiographic analysis
was routinely performed in the intensive care unit to exclude complications
in the lungs. Furosemide (1 mg/kg administered intravenously once daily)
andmethylprednisolone (0.5 mg/kg administered intravenously once daily)
were used in all patients to prevent pulmonary edema. Mechanical ventila-
tion was ceased once patients’ hemodynamics and spontaneous respiration
stabilized. Nonsteroidal anti-inflammatory drugs were prescribed to all
patients for postoperative pain relief. For patients with severe pain not re-
lieved by simple analgesics, opioid analgesics (intravenous fentanyl) were
also provided.rdiovascular Surgery c Volume 142, Number 4 851
FIGURE 2. Function of the 3 ports.
FIGURE 3. Aortic crossclamp and perfusion of cardioplegic solution.
Congenital Heart Disease Ma et al
C
H
DStatistical Analysis
SPSS software version 13.0 (SPSS, Inc, Chicago, Ill) was used for the
statistical analysis. Quantitative variables are expressed as means  stan-
dard deviations. Differences between multiple groups were compared by
means of 1-way analysis of variance. Categorical variables were compared
by using c2 tests.FIGURE 4. Closure of ventricular septal defect (VSD).RESULTS
Eighty-five patients were initially screened, and 36 were
recruited to this study. The main reasons for exclusion were
as follows: (1) less than 5 years old or body weight less than
20 kg (n¼ 35); (2) older than 5 years but the femoral artery
or vein was too small for canalization with a 10F catheter, as
determined by means of Doppler ultrasound examination,
(n ¼ 2); (3) pulmonary artery pressure of 60 mm Hg or
greater(n ¼ 9); and (4) history of lung disease or right-
sided chest operation preventing insertion of a thoracoscope
(n ¼ 3).
Of the selected patients, there were 16 male and 20 fe-
male patients with a mean age of 10.2  4.5 years (range,
5–19 years). The mean body weight was 30.4  10.6 kg
(range, 18–68 kg). Echocardiographic examination showed
perimembranous VSDs in all. The size of the defect ranged
from 4 to 14mm. Seven patients hadmild pulmonary hyper-
tension (pulmonary arterial pressure, 30–40 mm Hg), and 3
had moderate pulmonary hypertension (pulmonary arterial
pressure, 40–60 mm Hg). Four patients also had tricuspid
regurgitation caused by right ventricular dilation. Valvulo-
plasty with the DeVega technique was performed in 2 of
the 4 patients immediately after VSD repair in the same
procedure. Follow-up echocardiographic studies showed
no tricuspid regurgitation in these 2 patients.852 The Journal of Thoracic and Cardiovascular SurgIn the early stage of this study (the first 10 patients), 1 pa-
tient had bleeding caused by injury to the inferior vena cava
and right atrium. Another patient had bleeding from the
ascending aorta, where a needle was inserted to perfuse car-
dioplegic solution. In both cases the chest incision at port 2
was extended to 4 to 5 cm for better visualization of the
bleeding sites, and bleeding was successfully stopped
with sutures. Thoracoscopic VSD repair was successfully
completed after the bleeding from the inferior vena cava
or ascending aorta was stopped.
All patients survived the operation and were discharged
from the hospital in 2 to 6 days. No patient in this cohort un-
derwent reoperation for bleeding after the VSD repair. The
mean CPB time was 66.2  21.3 minutes (range, 54–142
minutes). The mean aortic crossclamp time was 36.4 
8.2 minutes (range, 25–57 minutes). Once the aortic clamp
was removed, heart beat resumed spontaneously in 27 pa-
tients. In 9 patients 50 W DC shock through the chestery c October 2011
TABLE 1. Comparison of operational data between the patients
undergoing thoracoscopic ventricular septal defect closure
Patients
1–10
Patients
11–20
Patients
21–36
P
value
Total operation time (min) 147  20 130  5 112  10 .003
CPB (min) 80  17 63  5 55  3 .002
Aortic crossclamp time (min) 46  7 34  5 28  3 .01
Mechanical ventilation time (h) 5.0  1.4 3.0  0.6 3.0  0.6 .01
Intensive care stay (h) 28  4 22  5 17  2 .01
Patients 21 to 36 included the 2 patients who underwent valvuloplasty during the
same procedure. CPB, Cardiopulmonary bypass.
TABLE 2. Comparison of operational data between the thoracoscopic
(study) and control groups
Study group
(n ¼ 16)
Control group
(n ¼ 16)
P
value
Age (y) 7  3 8  4 .11
Male sex 10 (62.5%) 9 (56.3%) .12
Total operation time (min) 112  10 126  30 .053
CPB (min) 55  3 56  11 .123
Aortic crossclamp time (min) 28  3 26  5 .098
Blood loss (mL) 50  22 110  33 .001
Mechanical ventilation (h) 3.0  0.6 3.6  1 .12
Intensive care unit stay (h) 17  2 25  5 .01
Hospital stay (d) 3.7  0.4 6.1  0.6 .03
Complications 0 1 (6.2%)* NS
Patients requiring opioid
analgesics
6 (37.5%) 14 (87.5%) .001
The study group included patients 21 to 36. CPB, Cardiopulmonary bypass. *Postop-
erative bleeding that did not require reoperation.
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to sinus rhythm. The mean mechanical ventilation time was
4.0  1.1 hours (range, 2–19 hours), and the mean duration
of intensive care unit stay was 20.0  4.1 hours (range,
20–28 hours). The total operation time, CPB time, aortic
crossclamp time, mechanical ventilation time, duration of
intensive care stay, and complication rates of the first, sec-
ond, and third groups of 10 patients are listed in Table 1.
There was a significant reduction in total operation time,
CPB time, aortic crossclamp time, and duration of intensive
care unit stay in the last 16 patients (P  .01).
In all patients transesophageal echocardiographic analy-
sis immediately after VSD repair showed complete closure
with no residual shunt. Two (5.6%) patients experienced
arrhythmia, and 1 had a high degree of atrioventricular con-
duction block, which spontaneously recovered within 24
hours after the operation. The other patient had atrial fibril-
lation after VSD repair, but sinus rhythm returned after 52
hours. One (2.8%) patient had right pulmonary atelectasis,
from which the patient recovered in 2 days after physiologic
therapy on the chest. There was a significant difference in
complication rates between the first 20 and the last 16
patients (15.0% vs 0%, P<.01).
Three (8.3%) patients required blood transfusion of 400
mL each during the procedure. The total volume of chest
drainage ranged from 30 to 460 mL (mean, 65  29 mL).
Patients have been followed up for 5.2 3.9 months (range,
3–12 months), with no signs of residual shunt on transtho-
racic echocardiographic analysis. There were no complica-
tions from the operation. Patients resumed work or
schooling between 14 and 23 days (median, 16 days) after
the operation.
As shown in Table 2, there was no significant difference
in age, sex, total operation time, CPB time, aortic cross-
clamp time, and mechanical ventilation time between the
thoracoscopic and control groups (P>.05). In the thoraco-
scopic group the blood loss during the operation was signif-
icantly less than in the control group (P< .01), and the
intensive care unit or total hospital stays were shorter
(P<.05). In the thoracoscopic group 6 patients required in-
travenous fentanyl (5–10 mg $ kg1 $ h1) for 1 to 2 days, and
the remainder were treated with simple analgesics, mostlyThe Journal of Thoracic and Caparacetamol. In the control group fentanyl was
administered to 14 (87.5%) patients (P< .01) for 1 to 5
days after the operation, and the remaining patients received
nonsteroidal anti-inflammatory drugs for pain relief.DISCUSSION
The computerized telemicromanipulator or surgical ro-
bot is a relatively new device for minimally invasive cardiac
surgery. Using this device, surgeons can manipulate small
instruments through small chest incisions to perform
procedures previously possible only with open exposure.2
The totally endoscopic technique has been used for ASD
repair,6-10 treatment of atrial fibrillation,10 and coronary
bypass grafting.11 Although the efficacy and safety of the
totally endoscopic technique are still under evaluation, re-
cent clinical results on ASD repair were quite encouraging
because the operation could be performed safely and with
no need for conversion to full sternotomy or minithoracot-
omy in all reported cases.5-9
A potential disadvantage that might hinder the wide-
spread use of the current totally endoscopic technique is
the reliance on the robotically assisted surgical system.
The complexity and costs of these computerized systems
might be an issue for some hospitals or patients, particularly
those from developing countries. In this study, based on the
previously reported endoscopic techniques,5-9 we derived
a totally thoracoscopic approach for the closure of
a perimembranous VSD without the need for robotic
assistance. The plastic retractors we made for the small
chest incisions greatly eased the insertion and
withdrawals of surgical instruments or thoracoscopy
through the 3 ports on the right chest. Successful repair of
the perimembranous VSD was achieved in all patients.
There were no life-threatening complications and no need
for converting to full sternotomy or minithoracotomy.rdiovascular Surgery c Volume 142, Number 4 853
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a perimembranous VSD without robotic assistance is feasi-
ble and safe.
As with robotically assisted endoscopic techniques, our
totally thoracoscopic approach was also associated with
learning-curve issues. In this study all procedures were
performed by a single operator (Z-S.M.). As shown in
Table 1, after the first 20 patients, the total operation times,
CPB times, and aortic crossclamp times were reduced to
112, 55, and 28 minutes, respectively. To date, there are
few published data on totally thoracoscopic VSD repair
that we can use for comparison. Reports on robotically as-
sisted endoscopic repair of ASDs showed CPB times of
122 to 135 minutes and aortic crossclamp times of 32 to
70 minutes.5-9 Therefore our operational data are
compared favorably with those of other groups, even
though VSD repair is technically more challenging than
ASD closure. These results suggest that after 20 patients,
an operator can achieve the competence for totally
thoracoscopic VSD repair, even without robotic assistance.
One of the potential limitations in this single-center study
is that only a small group of patients were involved and
follow-up was relatively short (3–12 months). The long-
term efficacy and safety of this technique are yet to be de-
termined in a large number of patients. Only older (>5
years) and larger (>20 kg) patients were included in this
study. Younger patients and those with smaller body weight
or size were not suitable for the current thoracoscopic tech-
nique because peripheral CPB was difficult to establish in
these patients as a result of relatively small femoral arteries
or veins. Finally, this totally thoracoscopic approach is only
suitable for perimembranous VSD closure. Supracristal or
muscular VSDs were difficult to access through the chest
ports. Therefore this type of VSD is better suited for con-
ventional open-chest closure.854 The Journal of Thoracic and Cardiovascular SurgIn conclusion, in patients with perimembranous VSDs,
totally thoracoscopic repair without a robotically assisted
surgical system appears feasible and safe. This novel tech-
nique is associated with a reduced intensive care and hospi-
tal stay in comparison with conventional surgical VSD
repair.
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